Not particularly. While the two target GLP-1 receptors, Tirz also activates GIP receptors, making it a twin agonist. This broader system is thought to reinforce its results on insulin sensitivity and appetite signaling in exploration versions. El reto farmacológico de esta clase de moléculas es el stability entre las tres https://peptisell.com/